Kati Hinkle
Payments from drug & device makers
Across 131 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$275
- Pfizer$99
- Otsuka America Pharmaceutical, Inc.$83
- Vanda Pharmaceuticals Inc.$81
- Braeburn Inc.$77
- plus $567 from 17 others
What the payments were for
- Food & beverage$2,332100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,150 |
| Lilly USA, LLC | 16 | $275 |
| Pfizer | 7 | $99 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 5 | $81 |
| Braeburn Inc. | 4 | $77 |
| Boehringer Ingelheim | 1 | $70 |
| Neurocrine Biosciences, Inc. | 4 | $66 |
| Novo Nordisk | 3 | $51 |
| Gilead | 3 | $46 |
| AstraZeneca | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| GSK | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Abbott | 1 | $26 |
| Amgen | 2 | $24 |
| Orexo US, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Indivior Inc. | 1 | $13 |
How this compares
$2,332 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 55 | $62,508 |
| MounjaroTirzepatide | 17 | $19,821 |
| OzempicSemaglutide | 18 | $16,813 |
| LinzessLinaclotide | 23 | $12,078 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 22 | $10,390 |
| EliquisApixaban | 18 | $10,288 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,396 |
| Repatha SureclickEvolocumab | 11 | $6,075 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $5,999 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,374 |
| JanuviaSitagliptin Phosphate | 11 | $4,752 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 23 | $3,940 |
| Leflunomide | 12 | $3,705 |
| VascepaIcosapent Ethyl | 14 | $2,262 |
| Omeprazole | 84 | $1,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $275 | $82,32972 claims |
| Novo NordiskOzempic | $51 | $16,81318 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $43 | $13,77029 claims |
| AbbVieLinzess | $1,150 | $12,07823 claims |
| GSKAnoro Ellipta | $35 | $10,39022 claims |
| PfizerEliquis | $99 | $10,28818 claims |
| Boehringer IngelheimCombivent Respimat | $70 | $5,99913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.
Other family in Salem
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.